Biogen (BIIB) PT Lowered to $236 at Guggenheim

March 22, 2019 11:10 AM
Guggenheim analyst Yatin Suneja lowered the price target on Biogen (NASDAQ: BIIB) to $236.00 (from $325.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles